Evolution of the Average Target: Lineage, Inc.

Evolution of the Target Price: Lineage, Inc.

Changes in Analyst Recommendations: Lineage, Inc.

1191a0f1bfb3ea45841cb7b2d5676626.v7piFZk74FvzIffllWui7WtHWJjVztZ0Fbl1-zATBdI.ye8jea8O0g2jRLmP_z_jrzkPMeGAuuM-R9gdoXFlPZ7gyBYk_UmHLJh7ug~3146e450a7674628bf9bac8098e4b0d9
06-17 Truist Adjusts Price Target on Lineage to $46 From $44, Maintains Buy Rating MT
06-02 Lineage Shows Early Recovery Signs as Demand Stabilizes, Morgan Stanley Says MT
06-02 Morgan Stanley Raises Price Target on Lineage to $47 From $39, Keeps Equalweight Rating MT
06-02 Analyst recommendations: Caesars Entertainment, Intuit, Caterpillar, Dell… Zonebourse
03-04 Truist Raises Price Target on Lineage to $44 From $41, Keeps Buy Rating MT
03-02 RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating MT
01-20 Truist Raises Price Target on Lineage to $41 From $40, Keeps Buy Rating MT
01-13 Lineage Shares Fall After Barclays Downgrade MT
01-13 Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 MT
01-08 UBS Adjusts Lineage Price Target to $35 From $41, Maintains Neutral Rating MT
12-23 Truist Cuts Price Target on Lineage to $40 From $53, Keeps Buy Rating MT
12-18 Baird Downgrades Lineage to Neutral From Outperform, Adjusts PT to $39 From $45 MT
12-18 Analyst recommendations: American Express, Merck, Rivian, Albemarle, Micron… Zonebourse
11-12 RBC Lowers Price Target on Lineage to $45 From $51, Keeps Outperform Rating MT
11-10 Lineage Insider Bought Shares Worth $345,630, According to a Recent SEC Filing MT
11-06 Piper Sandler Downgrades Lineage to Neutral From Overweight, Adjusts Price Target to $41 From $55 MT
25-10-14 UBS Adjusts Price Target on Lineage to $41 From $45, Maintains Neutral Rating MT
25-08-22 Truist Cuts Price Target on Lineage to $53 From $60, Keeps Buy Rating MT
25-08-18 RBC Cuts Price Target on Lineage to $51 From $64, Keeps Outperform Rating MT
25-08-11 BofA Securities Downgrades Lineage to Underperform From Neutral MT
25-07-23 UBS Adjusts Price Target on Lineage to $45 From $49, Maintains Neutral Rating MT
25-07-01 KeyBanc Downgrades Lineage to Sector Weight From Overweight on Valuation, Lower Growth Outlook, Removes $84 Price Target MT
25-07-01 Analyst recommendations: Hasbro, Lineage, Carnival, Fortive, Oracle… Zonebourse
25-06-23 Lineage Faces Downside Risks to H2 Recovery Amid Tariff Headwinds, Morgan Stanley Says MT
25-06-23 JPMorgan Downgrades Lineage to Underweight From Neutral, Adjusts Price Target to $50 From $55 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-1.91%
+0.28%
+4.26%
+6.07%
-6.47%
+28.9%
+22.64%
+7.22%
+33.86%
+16%
Average +11.09%
Weighted average by Cap. +3.26%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
44.00USD
Average target price
43.16USD
Spread / Average Target
-1.91%
High Price Target
63.00USD
Spread / Highest target
+43.18%
Low Price Target
35.00USD
Spread / Lowest Target
-20.45%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
Morgan Stanley
RBC Capital Markets
Barclays
UBS
Baird
Piper Sandler
BofA Securities
KeyBanc Capital Markets
JPMorgan Chase
Deutsche Bank Securities
BNP Paribas Exane
Scotiabank
Citigroup
Capital One Securities
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
44.00USD
Average target price
43.16USD
Spread / Average Target
-1.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LINE Stock
  4. Consensus Lineage, Inc.